Weekly oral prednisolone improves survival and strength in male mdx mice

Richard M. Keeling, Paul T. Golumbek, Elizabeth M. Streif, Anne M. Connolly

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


Although corticosteroids alleviate weakness in mdx mice, no long-term treatment has determined whether this benefit is maintained. We studied mdx mice forelimb grip strength and fatigue from 3 through 84 weeks and followed survival through 104 weeks. The mdx mice were given twice weekly oral prednisolone (5 mg/kg) beginning at 3 or 4 weeks. Treated mdx mice survived longer than untreated mice. Between 3 and 10 weeks, treated and untreated mdx mice had similar strength. Between 10 and 24 weeks, strength and strength per gram body weight declined more slowly in treated than untreated mdx mice. Between 24 and 84 weeks, treated and untreated mdx mice declined in strength at the same rate, although treated mice remained stronger. Forelimb grip fatigue was present in untreated mdx mice at all time-points compared to wild-type and was not changed significantly by treatment. We have demonstrated long-term benefit of oral prednisolone in the mdx mouse model of Duchenne muscular dystrophy (DMD). As corticosteroids remain the most validated long-term treatment of DMD, this work may allow for better prediction of synergistic treatments likely to translate to effective improvement for boys with this progressive muscular dystrophy.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalMuscle and Nerve
Issue number1
StatePublished - Jan 2007


  • Corticosteroids
  • Fatigue
  • Prednisolone
  • Strength
  • Survival
  • mdx mice


Dive into the research topics of 'Weekly oral prednisolone improves survival and strength in male mdx mice'. Together they form a unique fingerprint.

Cite this